Subscribe Sign In Register

Horizon Pharma

tourbillon-thumbnail.jpg
Premium
Tourbillon Thrives on a Heady Mix of PR and Performance
Jason Karp’s still-young hedge fund firm generates big numbers with an unusual long-short strategy — and a CIA interrogator.
Stephen Taub
June 9, 2015